OpenVSafe by OpenVAERS
Search V-safe

C2U-13475-73169

4 vaccinations 9 coded responses 25 check-ins 8 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
212 / MD
Registered
2021-11-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
XCS-11003-80248 Child or adolescent in my care · Male · 2021-11-08
3KL-19856-98879 Child or adolescent in my care · Male · 2022-06-23

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2574255 (opens in a new window) high 8 / 11 2 0 of 5 VAERS symptoms same dose (4) MD matches 2022-11-02 / 2023-01-11 / 2023-02-02
received the same day as the last call
case 145080

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-01-14
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-04
    Dose 2 — Pfizer-BioNTech
  3. 2021-11-08
    Registered in v-safe
  4. 2021-11-29
    Dose 3 — Pfizer-BioNTech
  5. 2021-11-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-12-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-12-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-12-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Swelling · None
    Adult check-in
  9. 2021-12-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oedema peripheral — Feeling: Fair · Site: Pain
    Free text: Swelling under arm where I got the shot
    MedDRA releases: 2024-11 · check-in free text available
  10. 2021-12-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oedema peripheral — Feeling: Good · Site: Pain
    Free text: Under arm swelling on arm where I got the shot
    MedDRA releases: 2024-11 · check-in free text available
  11. 2021-12-09
    Survey response — day 7, dose 3
    MedDRA: Oedema peripheral — Feeling: Good
    Free text: Under arm swelling
    MedDRA releases: 2024-11 · check-in free text available
  12. 2021-12-13
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  13. 2021-12-21
    Survey response — day 21, dose 3
    MedDRA: Nasal pruritus, Pruritus — Feeling: Fair
    Free text: Itchy nose and face
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-01-03
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  15. 2022-01-10
    Survey response — day 42, dose 3
    MedDRA: Nasopharyngitis — Feeling: Poor · Be unable to work or attend school
    Free text: Cold symptoms
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-03-01
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  17. 2022-05-30
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-11-02
    Dose 4 — Pfizer-BioNTech
  19. 2022-11-02
    Health check-in — day 0, dose 4
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  20. 2022-11-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  21. 2022-11-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  22. 2022-11-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  23. 2022-11-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Swelling · None
    Adult check-in
  24. 2022-11-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Swelling · Fatigue or tiredness
    Adult check-in
  25. 2022-11-11
    Health check-in — day 7, dose 4
    Feeling: Good · Site: Swelling · None
    Adult check-in
  26. 2022-11-23
    Survey response — day 21, dose 4
    MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat, nasal congestion
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-11-30
    Survey response — day 28, dose 4
    MedDRA: Dizziness, Eye pain, Headache, Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school
    Free text: Nasal congestion, sore throat, dizziness, headache, eye pain
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-12-09
    Survey response — day 35, dose 4
    MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school
    Free text: COVID
    MedDRA releases: 2024-11 · check-in free text available
  29. 2023-02-01
    Survey response — 3 months, dose 4
    MedDRA: Amenorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  30. 2023-02-01
    Report sent to call center — 3 months, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  31. 2023-02-02
    Call successful
    Completed over the phone
  32. 2023-05-03
    Health check-in — 6 months, dose 4
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Pfizer-BioNTech No
22021-02-04Pfizer-BioNTech No
32021-11-29Pfizer-BioNTech No
42022-11-02Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-04

Systemic reaction (other): Swelling under arm where I got the shot

2021-12-05

Systemic reaction (other): Under arm swelling on arm where I got the shot

Release 10 — day 7, dose 3

2021-12-09

Systemic reaction (other): Under arm swelling

Release 10 — day 21, dose 3

2021-12-21

Symptoms: Itchy nose and face

Release 10 — day 42, dose 3

2022-01-10

Symptoms: Cold symptoms

Release 12 — day 21, dose 4

2022-11-23

Symptoms: Sore throat, nasal congestion

Release 12 — day 28, dose 4

2022-11-30

Symptoms: Nasal congestion, sore throat, dizziness, headache, eye pain

Release 12 — day 35, dose 4

2022-12-09

Symptoms: COVID

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAmenorrhoea · · ✓
SDCOVID-19 · · ✓
SDDizziness · · ✓
SDEye pain · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDNasal pruritus · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓
SDPruritus · · ✓
SROOedema peripheral · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release